Posted: January 15th, 2023
Must post first.
Subscribe
Calcium and Vitamin D supplementation are essential to bone health and the management of osteopenia and osteoporosis. In the past few years, information regarding the potential risks of too much calcium (such as cardiovascular disease and/or events) have been emerging.
Gout is a common form of inflammatory arthritis that is very painful. It usually affects one joint at a time (often the big toe joint). Although there is no cure for gout, it can be effectively treated and managed with medication and self-management strategies
Feedback
98 / 100
Start a New Thread
Filter by:
All Threads
Sort by:
Most Recent Activity Least Recent Activity Newest Thread Oldest Thread Author First Name A-Z Author First Name Z-A Author Last Name A-Z Author Last Name Z-A Subject A-Z Subject Z-A
The efficacy of calcium supplementation, with and without vitamin D, has been questioned as to whether supplementation prevents or treats osteoporosis, and if any potential benefits outweigh risks such as GI upset, kidney stones, and adverse cardiovascular effects (Chiodini & Bolland, 2018). The European Society of Endocrinology (2018) published a research article titled, “Calcium Supplementation: Useful or Harmful?” where each author defended an opposing viewpoint regarding the usefulness for bone health versus potential harm of calcium supplementation. Chiodini (2018) argues that calcium with concomitant vitamin D supplementation in osteoporosis is useful and leads to an increase in bone mineral density (BMD) and a reduction of overall fractures by 15% and specifically hip fractures by 30%. Chiodini (2018) suggests that calcium and vitamin D supplementation should not be encouraged for patients with normal intake and lab values, but only for patients with low dietary intake and levels, particularly if osteoporotic and taking bone-active drugs. Chiodini (2018) states, “reported cardiovascular risk due to calcium supplementation is yet to be demonstrated and that studies that have evaluated the influence of dietary calcium intake did not show increase in the cardiovascular risk.”
The patient in question has a T-score of -2.3 which is indicative of low bone mass, or osteopenia (T-score between -1 and -2.5), and is quite close to the cut-off for a diagnosis of osteoporosis (T-score less than -2.5) (Bone Mass Measurement: What the Numbers Mean, 2018). It is indicated that the patient’s past medical history is unremarkable and that the only medication she is currently taking is a multivitamin with extra calcium and vitamin D. In addition to the patient’s T-score, the patient is post-menopausal and has a family history of osteoporosis, both of which are non-modifiable risk factors that increase her risk for osteoporosis. Nonpharmacologic practices that the patient should incorporate into her life to minimize her risk of bone loss include not smoking, increasing dietary calcium and vitamin D intake (can also be completed through UV exposure), partaking in weight-bearing and resistance exercises, and minimizing or eliminating alcohol use (Chisholm-burns et al., 2019). If the patient had a history of fracture after the age of 50, demonstrated historical height loss of 1.5 inches of more or prospective height loss of 0.8 inches or more, or had past or present long-term glucocorticoid use, then drug therapy such as denosumab, teriparatide, or zoledronic acid would be recommended (Chisholm-burns et al., 2019, Figures 56-2). However, with what is known about this patient, appropriate recommendations would include a bone-healthy lifestyle and calcium with vitamin D based on age and female gender (Chisholm-burns et al., 2019, Figures 56-2).
This patient possesses a few risk factors for an occurrence of gout which include being of the male sex, alcohol consumption, hypertension, and use of HCTZ, which can cause hyperuricemia (Chisholm-burns et al., 2019). The patient’s symptoms are consistent with an attack of gout in the respect that it was sudden, occurred in a joint, and was accompanied by severe pain (Mayo Clinic Staff, 2019). However, although these symptoms are highly suggestive of gout, they are not totally indicative, particularly since it was the patient’s first occurrence. Serum uric acid (SUA) levels may be beneficial in diagnosis, however, though often elevated they may be normal during an attack and therefore are not enough for a diagnosis (Chisholm-burns et al., 2019). In order to prevent a recurrence of gout, the patient can adhere to certain recommendations to decrease the amount of uric acid in his body such as drinking plenty of fluids, limiting or avoiding alcohol (particularly beer), consuming only low-fat dairy products, limiting intake of meat, fish, poultry, organ meats, and high-fructose corn syrup, as well as using an alternative anti-hypertensive medication and maintaining a healthy weight (Chisholm-burns et al., 2019; Mayo Clinic Staff, 2019). Since this was the patient’s first attack, non-pharmacologic interventions should be implemented and future attacks monitored as gout is an episodic disease and frequency of attacks vary to where it may or may not become a long-term issue for this patient. According to Chisholm-burns et al. (2019), patients with recurrent attacks of gout, defined as 2 or more per year, show evidence of tophus, are diagnosis with stage 2 CKD or worse, or history of urolithiasis are candidates for prophylactic therapy to lower SUA, and therefore, this patient does not meet criteria for prophylactic therapy. However, this patient should be advised to medicate with NSAIDs (treatment of choice- naproxen, indomethacin, and sulindac FDA approved for treatment of gout), colchicine, or corticosteroids at the first sign of his next attack to reduce pain and inflammation (Chisholm-burns et al., 2019).ReferencesChiodini, I., & Bolland, M. J. (2018). Calcium supplementation in osteoporosis: Useful or harmful? European Journal of Endocrinology, 178(4), D13–D25. https://doi.org/10.1530/eje-18-0113Mayo Clinic Staff. (2019, March 1). Gout – symptoms and causes. Mayo Clinic. https://www.mayoclinic.org/diseases-conditions/gout/symptoms-causes/syc-20372897 less0 UnreadUnread
Normal | Bone density is within 1 SD (+1 or −1) of the young adult mean. |
Low bone mass | Bone density is between 1 and 2.5 SD below the young adult mean (−1 to −2.5 SD). |
Osteoporosis | Bone density is 2.5 SD or more below the young adult mean (−2.5 SD or lower). |
Severe (established) osteoporosis | Bone density is more than 2.5 SD below the young adult mean, and there have been one or more osteoporotic fractures. |
The factors that affect serum uric acid (SUA) levels are age and gender, after puberty, SUA levels increases to reach normal level. In men, levels are higher than women, but at menopause, women SUA levels increase to reach men’s level Ragab et al. (2017). Therefore, gout is in the increase on middle aged men, older men and menopausal women. Alcohol is well known factor for gout, depending on the amount consumed and the type of alcohol. Beer is worst in increasing the risk of gout compared to liquor and the lowest risk is wine Ragab et al. (2017). Management of gout includes the use of colchicine, non-steroidal anti-inflammatory drugs (NSAIDs), and steroids, they can be taken together in severe symptoms. Colchicine when taken 12 hours of the flare up of gout shows to be more effective but the toxicity must be monitored such gastrointestinal intolerance, diarrhea, nausea or vomiting, neutropenia and multi-organ failure. Chung, M., University, F. T., Tang, A. M., Fu, Z., Wang, D. D., Newberry, S. J., . . . Margolis, K. L. (2016). Calcium Intake and Cardiovascular Disease Risk. Retrieved from https://www.acpjournals.org/doi/10.7326/M16-1165Föger-Samwald, U., Dovjak, P., Azizi-Semrad, U., Kerschan-Schindl, K., & Pietschmann, P. (2020). Osteoporosis: Pathophysiology and therapeutic options. EXCLI journal, 19, 1017–1037. https://doi.org/10.17179/excli2020-2591less0 UnreadUnread
less1 UnreadUnread12 ViewsViews
Place an order in 3 easy steps. Takes less than 5 mins.